BridgeBio Pharma Inc (BBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.25B
Last updated: Nov 17, 2026 at 11:05 AM ET
BridgeBio Pharma Inc (BBIO) Competitors
The companies most similar to BridgeBio Pharma are Bio-Techne (TECH), Krystal Biotech (KRYS) and TG Therapeutics (TGTX). By market cap, BridgeBio Pharma ranks 3rd of the 13 companies on this page; Roivant Sciences (ROIV) is the largest at $28.64B. The median P/E of the 6 companies with a P/E is 33.7x.
Peer Comparison
BBIO's ROIC of -33.0% is below the peer median of 9.3%, and its revenue growth of 192.6% is above the median of 29.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Madrigal Pharmaceuticals Inc (MDGL) | $9.93B | N/A | 8.7x | -10.9% | -12.7% | 50.1% | 0.00% |
| Exelixis Inc (EXEL) | $16.84B | 19.3x | 6.9x | 35.4% | N/A | 10.2% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Halozyme Therapeutics Inc (HALO) | $11.43B | 17.8x | 6.1x | 26.9% | 15.8% | 39.2% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Roivant Sciences Ltd (ROIV) | $28.64B | N/A | 679.3x | 0.0% | N/A | 2136.0% | 0.00% |
| Twist Bioscience Corp (TWST) | $7.40B | N/A | 14.3x | -28.3% | N/A | 27.9% | 0.00% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $10.08B | 33.7x | 11.1x | 5.9% | 9.3% | 29.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to BridgeBio Pharma, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Madrigal Pharmaceuticals Inc (MDGL) | Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates... | MDGL competitors |
| Exelixis Inc (EXEL) | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development... | EXEL competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| Halozyme Therapeutics Inc (HALO) | Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. | HALO competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Roivant Sciences Ltd (ROIV) | Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive... | ROIV competitors |
| Twist Bioscience Corp (TWST) | Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. | TWST competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... |
Frequently Asked Questions About BBIO
Who are BridgeBio Pharma's main competitors?
The companies most similar to BridgeBio Pharma include Bio-Techne (TECH), Krystal Biotech (KRYS), TG Therapeutics (TGTX), Madrigal Pharmaceuticals (MDGL) and Exelixis (EXEL), listed from the closest match.
Who is BridgeBio Pharma's biggest competitor?
Roivant Sciences (ROIV) is the largest of the similar companies at $28.64B; Bio-Techne (TECH) is the closest match by business profile, size, sector and industry.
How does BBIO stock compare with its competitors?
BBIO's P/S is 16.0x against a peer median of 11.1x; its net margin is -59.8% against a peer median of 5.9%.
Which of BridgeBio Pharma's competitors pays a higher dividend?
BridgeBio Pharma pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is BridgeBio Pharma bigger than its competitors?
No. BridgeBio Pharma is 3rd by market cap among the 13 companies on this page; the largest is Roivant Sciences (ROIV) at $28.64B.
BBIO pages: Overview, Earnings, Forecast, Financials, Competitors